Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 2 (1)
P 3 (1)

Trial Status

Completed8
Terminated2
Unknown2
Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (13)

Research Network

Activity Timeline